Published in Biol Psychiatry on August 08, 2005
Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths. Am J Psychiatry (2010) 3.36
Dimensions of oppositional defiant disorder as predictors of depression and conduct disorder in preadolescent girls. J Am Acad Child Adolesc Psychiatry (2010) 1.85
Pediatric bipolar disorder versus severe mood dysregulation: risk for manic episodes on follow-up. J Am Acad Child Adolesc Psychiatry (2010) 1.76
Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis. Bipolar Disord (2008) 1.59
Prevalence of bipolar disorder in children and adolescents with attention-deficit hyperactivity disorder. Br J Psychiatry (2011) 1.55
Multifinality in the development of personality disorders: a Biology x Sex x Environment interaction model of antisocial and borderline traits. Dev Psychopathol (2009) 1.45
Self-Regulation of Emotion, Functional Impairment, and Comorbidity Among ChildrenWith AD/HD. J Atten Disord (2010) 1.20
CBCL pediatric bipolar disorder profile and ADHD: comorbidity and quantitative trait loci analysis. J Am Acad Child Adolesc Psychiatry (2008) 1.19
The developmental psychopathology of irritability. Dev Psychopathol (2013) 1.16
Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research. Annu Rev Clin Psychol (2014) 1.15
Deconstructing oppositional defiant disorder: clinic-based evidence for an anger/irritability phenotype. J Am Acad Child Adolesc Psychiatry (2012) 1.15
Rages--what are they and who has them? J Child Adolesc Psychopharmacol (2009) 1.12
ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents. Child Adolesc Psychiatry Ment Health (2008) 1.11
Differential diagnosis of bipolar disorder in children and adolescents. World Psychiatry (2012) 1.03
Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD. Pediatrics (2010) 0.99
Anger and irritability symptoms among youth with ODD: cross-informant versus source-exclusive syndromes. J Abnorm Child Psychol (2012) 0.98
Rages or temper tantrums? The behavioral organization, temporal characteristics, and clinical significance of angry-agitated outbursts in child psychiatry inpatients. Child Psychiatry Hum Dev (2009) 0.97
Clinical characteristics of bipolar vs. unipolar depression in preschool children: an empirical investigation. J Clin Psychiatry (2008) 0.93
Practitioner review: the assessment of bipolar disorder in children and adolescents. J Child Psychol Psychiatry (2009) 0.91
Childhood attention-deficit/hyperactivity disorder and the emergence of personality disorders in adolescence: a prospective follow-up study. J Clin Psychiatry (2008) 0.91
The behavioral organization, temporal characteristics, and diagnostic concomitants of rage outbursts in child psychiatric inpatients. Curr Psychiatry Rep (2009) 0.89
Phenomenology, longitudinal course, and outcome of children and adolescents with bipolar spectrum disorders. Child Adolesc Psychiatr Clin N Am (2009) 0.89
Differentiating bipolar disorder-not otherwise specified and severe mood dysregulation. J Am Acad Child Adolesc Psychiatry (2013) 0.89
How does a Developmental Perspective inform us about the early Natural History of Bipolar Disorder? J Can Acad Child Adolesc Psychiatry (2013) 0.88
Liquid risperidone in the treatment of rages in psychiatrically hospitalized children with possible bipolar disorder. Bipolar Disord (2010) 0.88
Disruptive mood dysregulation disorder and chronic irritability in youth at familial risk for bipolar disorder. J Am Acad Child Adolesc Psychiatry (2014) 0.87
Attention deficit hyperactivity disorder characteristics: II. Clinical correlates of irritable mood. J Affect Disord (2012) 0.83
DSM-5: disruptive mood dysregulation disorder. Asian J Psychiatr (2014) 0.82
Early-onset bipolar spectrum disorders: diagnostic issues. Clin Child Fam Psychol Rev (2009) 0.81
Treatment Options for the Cardinal Symptoms of Disruptive Mood Dysregulation Disorder. J Can Acad Child Adolesc Psychiatry (2015) 0.81
Disruptive mood dysregulation disorder: current insights. Neuropsychiatr Dis Treat (2016) 0.79
Unfiltered Administration of the YMRS and CDRS-R in a Clinical Sample of Children. J Clin Child Adolesc Psychol (2014) 0.78
Helping Children Hospitalized for Rages. Psychiatr Times (2009) 0.77
Risk for emerging bipolar disorder, variants, and symptoms in children with attention deficit hyperactivity disorder, now grown up. World J Psychiatry (2015) 0.77
Future directions for research on youth with bipolar spectrum disorders. J Clin Child Adolesc Psychol (2013) 0.76
Bipolar disorder in children. Psychiatry J (2014) 0.76
Pediatric Mania: The Controversy between Euphoria and Irritability. Curr Neuropharmacol (2017) 0.75
The History, Diagnosis and Treatment of Disruptive Mood Dysregulation Disorder. Shanghai Arch Psychiatry (2016) 0.75
The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry (2007) 14.02
The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry (2006) 11.85
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med (2005) 5.81
The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med (2006) 5.56
The worldwide prevalence of ADHD: is it an American condition? World Psychiatry (2003) 5.30
Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med (2006) 3.57
Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry (2011) 3.26
Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 3.13
Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry (2008) 2.96
Development and natural history of mood disorders. Biol Psychiatry (2002) 2.90
Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry (2005) 2.87
Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics (2003) 2.79
PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am J Psychiatry (2006) 2.78
Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. JAMA (2008) 2.76
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry (2003) 2.66
Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry (2002) 2.65
Cognitive behavioral therapy for 4- to 7-year-old children with anxiety disorders: a randomized clinical trial. J Consult Clin Psychol (2010) 2.50
Attention-deficit/hyperactivity disorder in adults. JAMA (2004) 2.50
Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry (2012) 2.48
Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb Cortex (2006) 2.44
Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol (2007) 2.39
Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry (2002) 2.37
Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol (2004) 2.36
A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). Pediatrics (2004) 2.32
Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. Am J Psychiatry (2010) 2.31
Behavioral inhibition in preschool children at risk is a specific predictor of middle childhood social anxiety: a five-year follow-up. J Dev Behav Pediatr (2007) 2.20
Psychiatric comorbidity and functioning in clinically referred preschool children and school-age youths with ADHD. J Am Acad Child Adolesc Psychiatry (2002) 2.19
Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med (2002) 2.19
Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. Am J Psychiatry (2005) 2.18
What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J Atten Disord (2005) 2.16
Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry (2007) 2.11
Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry (2002) 2.10
Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther (2005) 2.08
Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry (2006) 2.03
A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 2.01
Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2002) 2.00
Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2008) 1.99
Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry (2003) 1.91
Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms. Ann Clin Psychiatry (2006) 1.89
Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res (2007) 1.87
Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry (2006) 1.87
A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 1.87
Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.86
The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med (2005) 1.83
Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.79
The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred population. J Autism Dev Disord (2010) 1.76
Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. J Pediatr (2005) 1.74
Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry (2009) 1.73
Psychopathology in females with attention-deficit/hyperactivity disorder: a controlled, five-year prospective study. Biol Psychiatry (2006) 1.73
Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol (2009) 1.70
Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging. Biol Psychiatry (2006) 1.70
Stimulants and sudden death: what is a physician to do? Pediatrics (2006) 1.64
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet (2011) 1.63
Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis. J Clin Psychopharmacol (2002) 1.60
Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder. J Pediatr (2009) 1.60
Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Arch Gen Psychiatry (2008) 1.59
A preliminary meta-analysis of the child behavior checklist in pediatric bipolar disorder. Biol Psychiatry (2003) 1.58
Symptoms versus impairment: the case for respecting DSM-IV's Criterion D. J Atten Disord (2006) 1.55
Association between attention-deficit/hyperactivity disorder and bulimia nervosa: analysis of 4 case-control studies. J Clin Psychiatry (2006) 1.55
Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder. Pediatrics (2005) 1.52
Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed (2006) 1.51
Attention and executive systems abnormalities in adults with childhood ADHD: A DT-MRI study of connections. Cereb Cortex (2007) 1.51
Long-term effects of extended-release mixed amphetamine salts treatment of attention- deficit/hyperactivity disorder on growth. J Child Adolesc Psychopharmacol (2005) 1.50
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol (2004) 1.49
Impact of low birth weight on attention-deficit hyperactivity disorder. J Dev Behav Pediatr (2002) 1.49
Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 1.48
Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD? J Child Psychol Psychiatry (2005) 1.47
Psychopathology in the offspring of parents with bipolar disorder: a controlled study. Biol Psychiatry (2005) 1.47
How cardinal are cardinal symptoms in pediatric bipolar disorder? An examination of clinical correlates. Biol Psychiatry (2005) 1.46
The Child Behavior Checklist-Pediatric Bipolar Disorder profile predicts a subsequent diagnosis of bipolar disorder and associated impairments in ADHD youth growing up: a longitudinal analysis. J Clin Psychiatry (2009) 1.45
MRI-based surface-assisted parcellation of human cerebellar cortex: an anatomically specified method with estimate of reliability. Neuroimage (2005) 1.44
Psychiatric comorbidity, family dysfunction, and social impairment in referred youth with oppositional defiant disorder. Am J Psychiatry (2002) 1.43
Pediatric bipolar disorder: the new perspective on severe mood dysfunction in children. J Child Adolesc Psychopharmacol (2003) 1.43
Clinical correlates of bipolar disorder in a large, referred sample of children and adolescents. J Psychiatr Res (2005) 1.43
A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. J Atten Disord (2002) 1.42
Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry (2008) 1.41
The CBCL predicts DSM bipolar disorder in children: a receiver operating characteristic curve analysis. Bipolar Disord (2005) 1.40
Attention-deficit/hyperactivity disorder endophenotypes. Biol Psychiatry (2005) 1.40
Towards conceptualizing a neural systems-based anatomy of attention-deficit/hyperactivity disorder. Dev Neurosci (2009) 1.39
Functional neuroanatomy of working memory in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 1.35
Further evidence of unique developmental phenotypic correlates of pediatric bipolar disorder: findings from a large sample of clinically referred preadolescent children assessed over the last 7 years. J Affect Disord (2004) 1.33
Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. J Clin Psychopharmacol (2009) 1.32
Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2005) 1.32
Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr (2006) 1.29
Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. J Am Acad Child Adolesc Psychiatry (2003) 1.29
Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry (2011) 1.26
The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr (2004) 1.26
Neuropsychological studies of late onset and subthreshold diagnoses of adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2006) 1.25